We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APPN icon
276
Appian
APPN
$1.88B
$433K 0.01%
+14,027
New +$460K
WHR icon
277
Whirlpool
WHR
$2.44B
$433K 0.01%
4,233
-1,914
-31% -$187K
IVT icon
278
InvenTrust Properties
IVT
$2.83B
$431K 0.01%
17,390
+2,920
+20% +$72.2K
BL icon
279
BlackLine
BL
$1.8B
$430K 0.01%
+8,870
New +$487K
COLL icon
280
Collegium Pharmaceutical
COLL
$1.15B
$428K 0.01%
13,296
+5,281
+66% +$183K
JBTM
281
JBT Marel
JBTM
$7.37B
$428K 0.01%
+4,502
New +$425K
NRC icon
282
NRC Health Common Stock
NRC
$479M
$427K 0.01%
18,620
+9,626
+107% +$297K
HPE icon
283
Hewlett Packard
HPE
$63.8B
$427K 0.01%
+20,154
New +$371K
ABT icon
284
Abbott
ABT
$182B
$426K 0.01%
+4,101
New +$435K
RGEN icon
285
Repligen
RGEN
$7.39B
$424K 0.01%
+3,362
New +$527K
STAA icon
286
STAAR Surgical
STAA
$1.14B
$423K 0.01%
+8,895
New +$390K
ET icon
287
Energy Transfer Partners
ET
$68.5B
$422K 0.01%
+26,024
New +$409K
PAHC icon
288
Phibro Animal Health
PAHC
$1.43B
$422K 0.01%
25,164
+12,731
+102% +$205K
APTV icon
289
Aptiv
APTV
$12.2B
$421K 0.01%
5,980
-998
-14% -$76.7K
GL icon
290
Globe Life
GL
$13.5B
$417K 0.01%
5,070
+1,707
+51% +$141K
UCTT
291
Ultra Clean Holdings
UCTT
$3.9B
$414K 0.01%
+8,449
New +$379K
AIG icon
292
American International
AIG
$42B
$413K 0.01%
+5,562
New +$425K
SBRA icon
293
Sabra Healthcare REIT
SBRA
$5.65B
$411K 0.01%
+26,660
New +$381K
CRM icon
294
Salesforce
CRM
$142B
$409K 0.01%
+1,589
New +$425K
ARE icon
295
Alexandria Real Estate Equities
ARE
$8.96B
$398K 0.01%
+3,399
New +$405K
PLL
296
DELISTED
Piedmont Lithium
PLL
$393K 0.01%
+39,415
New +$503K
STRA icon
297
Strategic Education
STRA
$1.78B
$393K 0.01%
+3,549
New +$393K
FTNT icon
298
Fortinet
FTNT
$112B
$391K 0.01%
6,484
-2,537
-28% -$158K
ATRC icon
299
AtriCure
ATRC
$1.89B
$389K 0.01%
17,068
-3,672
-18% -$84.7K
PH icon
300
Parker-Hannifin
PH
$124B
$384K 0.01%
+759
New +$407K
10 11
12
13 14

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.